演讲嘉宾


演讲嘉宾名单 | 路演公司

ChinaBio® 呈办的 BioBay 创业投资论坛的演讲嘉宾均来自中美两国在其领域享有美誉的专家,其中包括:

    • 对中国生物科技产业现状的阐述 - 中国的生物科技和生命科学产业正在迅速成长,成为为全球的中坚力量。苏州在中国生物科技产业发展中起到了重要的作用。
    • 吸引早期资本 - 了解中美投资者投资早中期的生物科技、诊断和服务公司的所看重的因素,聆听企业家们的成功案例。
    • 构建全球化的生物科技公司 - 如何运用美国、英属维尔京群岛、开曼、外商独资企业、股份公司、子公司等形式在中国建立国际性的生物科技企业。
    • 创建全球化的知识产权框架 - 如何建立可以在全球范围内成功保护知识产权的专利资产组合。
    • 通过外包服务以减少成本和降低风险 -  如何运用合同研究结构  (CROs) 及合同制造机构 (CMOs) 完成医药研发工作以减少成本并增加投资回报。

演讲嘉宾名单

以下产业界专家将在BioBay 创业投资论坛发表精彩演讲,阐释正在崛起的中国生物科技产业以及如何成功开启及创建生命科技公司。(点击这里看演讲嘉宾的详细介绍.)

ChinaBio® Executive Workshop 演讲嘉宾:

Kewen Jin, PhD – CEO, Charles River Laboratories (China)

Greg B. Scott – President and Founder, ChinaBio®

Zhaohui (Zoe) Wang, PhD, JD – Partner, Perkins Coie LLP

Wei Zhou, PhD, JD – Partner, Wilson Sonsini Goodrich & Rosati (WSGR)

BioBay 创业投资论坛演讲嘉宾和专题讨论嘉宾:

Amir Gal-Or, MBA – Managing Partner, Infinity Equity
William Hu, MBA – Principal, Qiming Venture Partners
Karen Liu, PhD, VP - China Renaissance Capital Investment
Yuwen Liu – General Manager, BioBay
Don Qiu, PhD, MBA – General Manager, China, ChinaBio® LLC
Yi Shi, PhD – Managing Director, Lilly Asian Ventures
David Xu, PhD - Managing Partner, Mingly China Growth Fund
Michael Xu, MD, PhD – CEO, PegBio Co., Ltd
Zhi Yang, PhD –Co-founder and Managing Partner, BioVeda China
Qimin Zhan, MD – Chief Scientist, State 863 Program
Dongchi Zhang - Director, Science & Technology Bureau, Suzhou Industrial Park
Peter Zhang, PhD - Chairman & CEO, Suzhou GenePharma Co., Ltd.

路演公司

以下公司将在 BioBay 创业投资论坛进行项目融资路演. (Final List)

 

Company / Speaker

Description

4D Pharmaceuticals Inc. (USA/China) 
Yongliang Zhu, PhD, Founder & President   
Novel drugs for the treatment of inflammation, cancer and CNS diseases Ascepion Pharmaceuticals, Inc.
Shan Jiang, PhD, CEO
Novel small molecule kinase inhibitor drugs Botanovation (Suzhou) Bioscience
Kevin Xu, MD, PhD, MBA CEO & Founder
Botanical technologies and products CareRay Digital Medical System
Jianqiang Liu, PhD, Founder, CTO & CEO
X-ray flat-panel detector in medical Industry GeneDiag Biotech (Suzhou)
Jingde Zhu, PhD, CSO & President
DNA methylation diagnotic products for cancer Suzhou GenePharma Co., Ltd.
Peter Zhang, PhD, Chairman & CEO
RNAi based services, products, diagnostic kits and therapeutics Suzhou Goodee Pharmaceutical
Guoxia Han, PhD, Co-founder & CEO
Novel anti-tumor drug discovery Suzhou Harmony Biotechnology
Janckie Zhu, VP
Novel drugs and synthesis contract research services Innogene Biotech Ltd. (Canada/China)
Qinghua Wang, MD, PhD, CEO & Founder 
Novel drugs for the treatment of type 1 and type 2 diabetes Kintor Pharmaceuticals, Inc. (USA/China)
Youzhi Tong, PhD, President
Signal transduction drugs for targeted cancer therapy NuHigh Biotechnologies Co., Ltd. (USA/China)
Wanli Bi, PhD, CTO 
Nucleic acid testing of blood supply Suzhou Scientific Solution Co., Ltd.
Yongtai Hou, PhD, Chairman & CEO
Nanotechnology platform to improve drug solubility SinoVitae Pharmaceuticals, Inc. (USA/China)
Augustine Lin, PhD, CEO & President
Point-of-care therapeutic diagnostic products Suzhou Sirnaomics Biopharmaceuticals Co., Ltd.
Patrick Lu, PhD, CEO
Drug development based on siRNA technologies Stainwei Biotech, Inc. (Suzhou)
Qunmin (Jim) Zhou, MD, PhD, Founder & President 
Novel antibody based anti-tumor angiogenesis drugs Viagene Biotech, Inc. (USA/China)
Richard Y Liu, MD, CEO & Founder 
Novel technologies & products for research and diagnosis Suzhou Sirnaomics Pharmaceuticals Co. Ltd.
Patrick Y. Lu, PhD. Founder, Chairman & CSO
Developing siRNA therapeutics to treat critical human diseases

 

 

>> 点击这里注册

主办方

金牌赞助

VC合作伙伴

媒体伙伴

ChinaBio® 会议

China Showcase 2020

美国,旧金山
2020年1月12号

ChinaBio 合作论坛2020

中国,苏州
2020年5月6-7号

合作伙伴会议

官方合作伙伴